iifl-logo-icon 1

Vardhaman Laboratories Ltd Share Price

0.51
(4.08%)
Aug 16, 2019|02:10:39 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vardhaman Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

0.51

Prev. Close

0.49

Turnover(Lac.)

0

Day's High

0.51

Day's Low

0.51

52 Week's High

0

52 Week's Low

0

Book Value

4.82

Face Value

10

Mkt Cap (₹ Cr.)

0.21

P/E

0

EPS

0

Divi. Yield

0

Vardhaman Laboratories Ltd Corporate Action

No Record Found

Vardhaman Laboratories Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vardhaman Laboratories Ltd SHAREHOLDING SNAPSHOT

25 Dec, 2024|12:25 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 37.19%

Foreign: 0.00%

Indian: 37.19%

Non-Promoter- 0.11%

Institutions: 0.10%

Non-Institutions: 62.69%

Custodian: 0.00%

Share Price

Vardhaman Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2018Mar-2017Mar-2016Mar-2015

Equity Capital

4.12

4.12

4.12

4.12

Preference Capital

0

0

0

0

Reserves

-2.13

-2.09

-2.05

-2.02

Net Worth

1.99

2.03

2.07

2.1

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2018Mar-2017Mar-2016Mar-2015

Revenue

0

0

0

0

yoy growth (%)

0

0

0

0

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

0

0

0

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2018Mar-2017Mar-2016Mar-2015

Profit before tax

-0.04

-0.03

-0.03

-0.02

Depreciation

0

0

0

0

Tax paid

0

0

0

0

Working capital

-0.04

-0.04

-0.02

-0.02

Other operating items

View Cash Flow
Y/e 31 MarMar-2018Mar-2017Mar-2016Mar-2015

Growth matrix (%)

Revenue growth

0

0

0

0

Op profit growth

1.71

-6.03

43.03

42.69

EBIT growth

7.75

18.33

20.38

19.33

Net profit growth

7.75

18.33

20.38

19.33

View Ratios

No Record Found

Vardhaman Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,817.6

158.194,36,103.12863.290.745,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,783.75

83.581,53,540.395180.522,302513.62

Mankind Pharma Ltd

MANKIND

2,910.4

59.911,20,073.47634.4302,529.74334.18

Cipla Ltd

CIPLA

1,475.9

28.161,19,195.761,178.160.883,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,401.2

70.361,15,106.894600.822,376222.38

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vardhaman Laboratories Ltd

Management

Register Office

Registrar Office

Chairman

Dharamchand Shah

Director

Sunil D Shah

Director

Sumedh Shah

Director

Dayanand Naik

Director

Umesh Patil

Director

Rajendra Petare

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vardhaman Laboratories Ltd was incorporated on 24th April, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited ans subsequently converted into a Public Limited vide Special Resolution dated 15th October, 1993 and obtained a fresh Certificate of Incorporation to change of name on 7th December, 1993 as Vardhaman Laboratories Limited, from the Registrar of Companies Maharashtra, Bombay, Consequent on the conversion of the company from Pvt. Ltd to Public Ltd.At present the Company is engaged in manufacturing varieties of formulations and marketing under the brand name of Samrat gained sizable popularity in the area of Western Maharashtra and Southern part of India.The Company started its operation on a small scale basis and during this time was also in the process of identifying a viable project in the pharmaceutical industry. After a thorough and exhastive study, the project for manufacturing the Bulk Drugs as mentioned aboves was conceived in December 1993.During 1998-99, the company has added new formulation products like Ciprofloxin, Norfioxaoin, Ranitidine, etc. It has also obtained export orders for Cotrimethaxile tablets & Paracetemol Caffeine tablets which has been completed.
Read More

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp